Syrian Arab News Agency S A N A
Related Articles
Tehran, SANA- Syria and Iran discussed means to enhance bilateral cooperation in domain of pharmaceutical industry and the medical equipment needed by Syria.
Assistant Health Minister for Medical and Pharmaceutical Affairs Dr. Habib Abboud, during his meeting with representatives of the Iranian Health Ministry, Pharmacists Syndicate and Iranian pharmaceutical companies in Tehran Wednesday, stressed the importance of focusing on the quality and the international standards of the medicines which are exported to Syria with competitive prices.
He called for overcoming all obstacles facing the process of bilateral cooperation in domain of producing and importing medicines and medical equipment.
Dr. Abboud also called for establishing production lines of medicines and the raw materials used in the pharmaceutical industry in Syria, affirming that all facilitations have been provided in this regard.
He affirmed the importance of qualifying specialized cadres needed in pharmaceutical industry to localize this industry in Syria, and implementing the agreements signed between the two countries in the health sector and upgrading them to meet the needs of this sector in Syria.
For his part, Syria’s Ambassador to Iran Dr. Adnan Mahmoud called for activating the memo of understanding signed between the two countries and setting the legal and procedural frameworks for building an economic partnership in framework of pharmaceutical industries and exchange of technology and Iranian experiences.
Mahmoud said that the Syrian Government and Health Ministry have provided all the required facilitations to the Iranian companies to provide the needs of the Syrian market.
In turn, representatives of Iranian Health Ministry and pharmaceutical companies expressed full readiness to enhance cooperation with Syria in different fields of pharmaceutical industries and medical equipment and to provide all the required expertise.
They also expressed willingness to contribute to the reconstruction process in Syria, affirming keenness on providing the medicines needed by Syria with international standards and competitive prices.
R. Jazaeri/Ghossoun
